NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in PatientsWith Brain Metastases (BM)
Conference
Wefel, Jeffrey S, Pugh, Stephanie, Gondi, Vinai et al. (2019). NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in PatientsWith Brain Metastases (BM)
. NEUROSURGERY, 66 137-138.
Wefel, Jeffrey S, Pugh, Stephanie, Gondi, Vinai et al. (2019). NRG Oncology CC001 Neurocognitive Final Analysis: A Phase III Trial of Hippocampal Avoidance (HA) in Addition to Whole-Brain Radiotherapy (WBRT) Plus Memantine to Preserve Neurocognitive Function (NCF) in PatientsWith Brain Metastases (BM)
. NEUROSURGERY, 66 137-138.